澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NOXOPHARM LTD

0.070

0.000

成交量：- -

成交額：- -

市值：2,045.67萬

市盈率：-4.19

高：0.070

開：0.070

低：0.070

收：0.070

52周最高：0.135

52周最低：0.043

股本：2.92億

流通股本：1.96億

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.017

每股收益(LYR):-0.017

淨資產收益率：-157.93%

總資產收益率：-59.24%

市淨率：29.65

市盈率(LYR):-4.19

資料載入中...

總覽公司新聞資訊公告

概念

新冠治療股-0.35%

醫藥生物股-1.76%

資金流向

資金流入：

資金流出：

新聞資訊

單月暴升逾140%！Noxopharm (ASX:NOX) 紅斑狼瘡候選藥SOF-SKN臨試即將推進第二隊列

澳洲财经见闻

快訊-澳大利亞Noxopharm啓動自體免疫藥物試驗股價飆升

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NOX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NOX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","market":"AU","secType":"STK","nameCN":"NOXOPHARM LTD","latestPrice":0.07,"timestamp":1771909920000,"preClose":0.07,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"NOXOPHARM LTD","floatShares":195506720,"shares":292237950,"eps":-0.016712,"marketStatus":"未開盤","change":0,"latestTime":"02-24 16:12:00 AEDT","open":0.07,"high":0.07,"low":0.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.016712,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1771974000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.07,"openAndCloseTimeList":[[1771887600000,1771909200000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","floatShares":195506720,"roa":"-59.24%","roe":"-157.93%","lyrEps":-0.016712,"shares":292237950,"dividePrice":0,"high":0.07,"amplitude":0,"preClose":0.07,"low":0.07,"week52Low":0.043,"pbRate":"29.65","psRate":"7.25","week52High":0.135,"institutionHeld":0,"latestPrice":0.07,"eps":-0.016712,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.016712,"open":0.07,"prevYearClose":0.093,"prevWeekClose":0.073,"prevMonthClose":0.077,"prevQuarterClose":0.093,"fiveDayClose":0.073,"twentyDayClose":0.08,"sixtyDayClose":0.089,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NOX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NOX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NOX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555573833","title":"單月暴升逾140%！Noxopharm (ASX:NOX) 紅斑狼瘡候選藥SOF-SKN臨試即將推進第二隊列","url":"https://stock-news.laohu8.com/highlight/detail?id=2555573833","media":"澳洲财经见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555573833?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 20:35","pubTimestamp":1753965300,"startTime":"0","endTime":"0","summary":"临床阶段生物科技公司 Noxopharm Ltd (ASX股票代码:NOX) 股价连日异动，周二早盘再度飙涨39%，触及…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e5%8d%95%e6%9c%88%e6%9a%b4%e6%b6%a8%e8%b6%85140%ef%bc%81noxopharm-asxnox-%e7%ba%a2%e6%96%91%e7%8b%bc%e7%96%ae%e5%80%99%e9%80%89%e8%8d%afsof-skn%e4%b8%b4%e8%af%95%e5%8d%b3%e5%b0%86%e6%8e%a8/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","SOF","NOX.AU","BK7508"],"gpt_icon":0},{"id":"1155127986","title":"快訊-澳大利亞Noxopharm啓動自體免疫藥物試驗 股價飆升","url":"https://stock-news.laohu8.com/highlight/detail?id=1155127986","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155127986?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 11:46","pubTimestamp":1752637570,"startTime":"0","endTime":"0","summary":"澳大利亚生物科技企业Noxopharm(NOX.AX)股价单日暴涨近46%至0.07澳元，创下去年10月4日以来最大单日涨幅。盘中股价触及6月6日以来最高点，此前该公司宣布自体免疫疾病候选药物SOF-SKN完成首例受试者给药。\n市场交投热度骤增，当日成交量达422,086股，达到30日平均交易量的2.2倍。值得关注的是，尽管今日股价强势反弹，该股年内累计跌幅仍达24.7%。\nSOF-SKN作为治疗自体免疫疾病的创新药物，其临床试验进展引发市场强烈反应。投资者密切关注该药物后续研发进程，这将成为影响企业估值走势的关键变量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NOX.AU","BK7067","BK7501","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NOX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治療股","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":-0.003499},{"market":"AU","name":"醫藥生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.017553}]}}